scispace - formally typeset
A

Astradur B. Hreidarsson

Researcher at RMIT University

Publications -  18
Citations -  5936

Astradur B. Hreidarsson is an academic researcher from RMIT University. The author has contributed to research in topics: Genome-wide association study & Type 2 diabetes. The author has an hindex of 14, co-authored 18 publications receiving 5242 citations. Previous affiliations of Astradur B. Hreidarsson include University of Iceland.

Papers
More filters
Journal ArticleDOI

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

Andrew P. Morris, +232 more
- 01 Sep 2012 - 
TL;DR: This article conducted a meta-analysis of genetic variants on the Metabochip, including 34,840 cases and 114,981 controls, overwhelmingly of European descent, and identified ten previously unreported T2D susceptibility loci, including two showing sex-differentiated association.
Journal ArticleDOI

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.

Anubha Mahajan, +395 more
- 01 Mar 2014 - 
TL;DR: In this paper, the authors aggregated published meta-analyses of genome-wide association studies (GWAS), including 26,488 cases and 83,964 controls of European, east Asian, south Asian and Mexican and Mexican American ancestry.
Journal ArticleDOI

An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans

Robert A. Scott, +216 more
- 01 Nov 2017 - 
TL;DR: This article conducted a meta-analysis of genome-wide association data from 26,676 T2D case and 132,532 control subjects of European ancestry after imputation using the 1000 Genomes multiethnic reference panel.
Journal ArticleDOI

Loss-of-function mutations in SLC30A8 protect against type 2 diabetes

Jason Flannick, +103 more
- 01 Apr 2014 - 
TL;DR: In this article, the authors identified 12 rare protein-truncating variants in SLC30A8, which encodes an islet zinc transporter (ZnT8) and harbors a common variant (p.Trp325Arg) associated with T2D risk and glucose and proinsulin levels.